Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

Sonrotoclax Plus Zanubrutinib Generates Responses in Treatment-Naive CLL/SLL
Venetoclax-Based Therapy Is Associated With Worse Outcomes in BTK Inhibitor–Resistant, Chemo-Naive CLL

December 19th 2024

Venetoclax-based treatment was associated with poorer outcomes in CLL previously treated with a BTK inhibitor and naive to chemotherapy.

The OncFive: Top Oncology Articles for the Week of 12/18
The OncFive: Top Oncology Articles for the Week of 12/8

December 14th 2024

Chronic Lymphocytic Leukemia | stock.adobe.com
Pirtobrutinib Improves PFS in Previously Treated CLL/SLL

December 10th 2024

Chronic Lymphocytic Leukemia |  © LAZLO- stock.adobe.com
First-Line Pirtobrutinib Plus Venetoclax/Obinutuzumab Generates High uMRD Rates in CLL

December 10th 2024

Sonrotoclax Plus Zanubrutinib Generates Responses in Treatment-Naive CLL/SLL
Sonrotoclax Plus Zanubrutinib Generates Responses in Treatment-Naive CLL/SLL

December 10th 2024

<1
...